This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 238 Users Online

Frontotemporal Dementia Treatment Market

Frontotemporal Dementia Treatment Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 - 2028

Frontotemporal Dementia Treatment Market Segmented By Drug class Type such as Antidepressants (Fluoxetine, Fluvoxamine, Sertraline, Paroxetine, Citalopram, Bupropion, Mitrazepine); Antipsychotics (Olanzepine, Quetiapine, Ziprasidone, Aripiprazole, Risperidone, Paliperidone)


Frontotemporal dementia occurs when the injury takes place to the particular area of the brain whether it is temporal or frontal, Frontotemporal mutilation results in the dementia which alters the dialect. Identity, development of muscle and identity. In Frontotemporal dementia, several conceivable indication could result, comprising trouble in walking, and working.

The degeneration of frontotemporal lob is primarily triggered due to proteins involvement TDP43 and tau which directly outbreak the damage on the temporal and frontal lobes of the brain. Frontotemporal dementia is mainly categorized into primary three forms, Primary progressive aphasia. (PPA.), Behavior Variants Frontotemporal Dementia. (BFTD), and Disturbances of motor function.

There absence of curable treatment for frontotemporal dementia but certain medication can benefit in plummeting the emotional disturbance and crabbiness as well as depression. According to Centers for Disease and Control, in 2010, about 35.8 million individuals were affected by Frontotemporal dementia across the globe although it is expected to affect around 115.7 million individuals by 2050.

Frontotemporal dementia progressively increases with respect to phase of dementia and leading to higher mortality rates.  Drugs such as antipsychotics and antidepressants can assist in treating symptoms of frontotemporal dementia.

Although the cause for Frontotemporal dementia is still unknown it majorly affects the individual between the ages of 40 to 60. Frontotemporal dementia causes serious psychotic episodes and language and communication problems not limited patient only but affects people around them.

The growing aging population globally is gradually increasing the number of new cases of dementia registered directly affecting the demand for frontotemporal dementia treatment market. The higher prevalence of frontotemporal dementia resulted in various new initiative and arrangements such as mental treatment centers, home care organizations, and restorative devices in aiding frontotemporal dementia patients, which is anticipated to drive the demand for frontotemporal dementia treatment market.

However, lack of proper diagnosis and higher chances of misunderstanding with Alzheimer’s disease is restraining the growth of the frontotemporal dementia treatment market. Additionally poor treatment regimens lack of novel therapies is also limiting the Frontotemporal dementia treatment market growth.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Market Segmentation

by Drug class Type
  • Antidepressants
    • Fluoxetine
    • Fluvoxamine
    • Sertraline
    • Paroxetine
    • Citalopram
    • Bupropion
    • Mitrazepine
  • Antipsychotics
    • Olanzepine
    • Quetiapine
    • Ziprasidone
    • Aripiprazole
    • Risperidone
    • Paliperidone
by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Drug Store
  • Online Pharmacy 
by Geographically
  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding china
  • China
  • Middle East & Africa

The global Frontotemporal dementia treatment market is remarkably fragmented due to presence of very large manufacturers in the market. The higher number of market players in the industry has offed them a significant competitive strength in the global frontotemporal dementia treatment market. Aiding their high share in the frontotemporal dementia treatment market.

The key players is primarily focused on adopting to the latest technological advancement in drug manufacturing and offering drugs with the reduced side effect for the frontotemporal dementia treatment. The research and development in advanced gene therapy particularly in the fields of neurodegeneration is offering the manufacturers in frontotemporal dementia treatment market a prime scope for competition.

The recent sanction on one of the frontotemporal dementia treatment drug as orphan drug status is anticipated to lure new market entrants in frontotemporal dementia treatment market.

North America leads the overall Frontotemporal dementia Treatment Market.  Advancement in health care facilities, continuous lifestyle changes, increase awareness about dementia, increase in disposable income and favorable government policies have boosted the global Frontotemporal dementia treatment market in North America. Also in Asia region higher market growth rate is expected due to increase in prevalence and incidence rates of Frontotemporal dementia due to aging population.

Some of the major key players competing in the global Frontotemporal dementia Treatment Market are Sanofi S.A., Novartis AG, F. Hoffmann-La Roche, AstraZeneca GmbH, Merck & Co., Valeant Pharmaceutical International, and Pfizer, among others.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

The report covers exhaustive analysis on:

  • Frontotemporal dementia treatment Market Segments
  • Frontotemporal dementia treatment Market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Frontotemporal dementia treatment Market Size & Forecast 2018 to 2026
  • Frontotemporal dementia treatment Agents Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Frontotemporal dementia treatment Market Drivers and Restraints
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding china
  • China
  • Middle East & Africa
Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

- Companies Covered in This Report -

Google translate